Skip to main content

First peanut allergy drug gets US approval

Biopharmaceutical company Aimmune Therapeutics says the US Food and Drug Administration has approved its drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17 and that it had priced it at $US890 ($A1,330) per month.

from Breaking News | Daily Telegraph https://ift.tt/2S3JX5k

Comments

Popular posts from this blog

El valor del bitcóin alcanza los 100.000 dólares

By David Yaffe-Bellany from NYT En español https://ift.tt/4oaX5Yi

Pagers Belonging to Hezbollah Militants Explode Across Lebanon

By Axel Boada from NYT World https://ift.tt/8etf4Yr

Pelosi Hospitalized in Luxembourg After Falling

By Annie Karni from NYT U.S. https://ift.tt/OM3CtY5